
EASL Podcasts
The EASL Podcast collection includes educational episodes derived from the EASL Studio, the EASL DeepDive webinars and the EASL Policy Dialogues. Listen to and stay abreast of the latest science and knowledge in Hepatology!
Episodes
117 episodes
EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency
In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency.Learning objectives:Learn mo...
•
1:07:15

EASL DeepDive: Understanding and managing PBC symptoms
In this EASL DeepDive held on 03 July 2024, Palak Trivedi, Emma Culver, Andreas Kremer and Jessica Dyson explain the risk assessment in people with PBC as well as the mechanistic and treatment of fatigue and pruritus.Learning objectiv...
•
1:15:22

EASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?
In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they revi...
•
1:06:16

EASL DeepDive: What is the future of PBC treatment?
In this EASL DeepDive held on 25 February 2025, Ana Lleo, Adriaan van der Meer, Gideon Hirschfield, and Bettina Hansen explore the future of primary biliary cholangitis (PBC) treatment. Discover the emerging therapies, current challenges ...
•
59:19

EASL Studio Podcast: JHEP Live: JHEP at 40: What to Expect Next?
This episode celebrates 40 years of the Journal of Hepatology, EASL’s flagship journal.Tune in to discover how far we’ve come—and what’s next for the journal.Moderator: Thomas Berg Faculty: Paolo Angeli, ...
•
Season 8
•
Episode 9
•
1:02:22

EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions
Rare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in th...
•
Season 8
•
Episode 8
•
44:52

EASL Studio Podcast: From Evidence to Action: Reducing Alcohol-Related Harm
This episode of EASL Studio explores insights from the European Alcohol Health Alliance Symposium, hosted by the WHO Regional Office for Europe in collaboration with EASL. Topics include managing alcohol marketing strategies, addressing gaps in...
•
Season 8
•
Episode 7
•
32:05

EASL Studio Podcast: Understanding Sex Disparities in MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects men and women differently, yet sex-based differences remain poorly explored. In the week celebrating International Women’...
•
Season 8
•
Episode 6
•
40:40

EASL Studio Podcast: Lessons from Your PET: Understanding and Evaluating Treatment for Wilson’s Disease
Tune into this EASL Studio episode to learn about the role of PET imaging in Wilson’s disease. Discover how PET advances understanding, supports treatment decisions, and enhances patient care in managing this rare liver disorder.Moder...
•
Season 8
•
Episode 5
•
38:48

EASL Studio Podcast: Liver cancer care in 2025: Progress, hope, and what lies ahead
Join this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping th...
•
Season 8
•
Episode 4
•
44:46

EASL Studio Podcast: YI choice: From idea to abstract to publication: Navigating your research journey
Watch this EASL Studio to start navigating your research journey with essential tips on generating ideas, refining hypotheses, and crafting standout abstracts for EASL Congress. Discover how to choose the right journal, prepare a submission-rea...
•
Season 8
•
Episode 3
•
31:49

EASL Studio Podcast: JHEP Live – EASL CPGs on hepatocellular carcinoma: What’s new and how will practice change?
Discover the latest updates from the updated EASL Clinical Practice Guidelines on Hepatocellular Carcinoma (HCC). This episode explores key advancements, their impact on clinical practice, and how they will shape the future of HCC diagnosis, tr...
•
Season 8
•
Episode 2
•
48:38

EASL Studio Podcast: 2025 update on steatotic liver disease: Rethinking standard of care
Join us for the season premiere of EASL Studio Season 8 as we unpack key insights from the Steatotic Liver Disease (SLD) Summit. Explore the evolving consensus on patient trajectories, advancements in ALD and MetALD treatment pathways, and the ...
•
Season 8
•
Episode 1
•
34:33

EASL Studio Podcast: The liver as a master regulator of ageing, health, and longevity
This EASL Studio showcases cutting-edge research elucidating the role of the liver in ageing and exploring its role as a regulator of health and longevity. In particular, the liver’s function in modulating systemic ageing, its ability to buffer...
•
Season 7
•
Episode 10
•
35:56

EASL Studio Podcast: TIPS: How far can we go?
This EASL Studio episode examines the current relevance of Hepatic Encephalopathy (HE) and the roles of hepatologists and interventional radiologists in patient care. The discussion covers technical approaches, patient outcomes, and the expandi...
•
Season 7
•
Episode 9
•
36:16

EASL Studio Podcast: Sarcopenia: Converting research findings into clinical practice - Are we doing enough?
Sarcopenia, defined by a reduction in muscle mass and strength, significantly increases the risk of hospitalisation and mortality in patients with liver cirrhosis. This EASL Studio episode highlights the importance of incorporating sarcopenia a...
•
Season 7
•
Episode 8
•
30:38

EASL Studio Podcast: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapies
This EASL Studio episode explores how alcohol worsens liver disease in patients with cardiometabolic risks, the stigma affecting diagnosis and care, and the latest therapeutic advances.Key topics of discussion include:Interac...
•
Season 7
•
Episode 7
•
35:44

EASL Studio Podcast: What’s hot and not in liver transplantation: EASL CPG 2024 update
Join the experts as they explore the new updates to the liver transplantation clinical practice guidelines, and delve into the latest advancement and ongoing challenges faced in this field.Tune in to:Discover cutting-edge tec...
•
Season 7
•
Episode 6
•
44:56

EASL Studio Podcast: Why does WHO engagement with Steatotic Liver Disease matter?
This episode is organised in collaboration with the Healthy Livers, Healthy Lives Coalition.FacultyJeffrey Lazarus (Moderator)Mazen Noureddin (Facult...
•
Season 7
•
Episode 5
•
36:16

EASL Studio Podcast: Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?
This episode explores the latest developments in liver disease, with a focus on metabolic-associated steatotic liver disease (MASLD) and its impact on liver cancer, particularly hepatocellular carcinoma (HCC). The main focus is the emerging rol...
•
Season 7
•
Episode 4
•
49:56

EASL Studio Podcast: Are we relearning how to manage renal dysfunction in cirrhosis?
Renal dysfunction is a significant concern for patients with liver cirrhosis, affecting nearly 50% of those hospitalised and leading to various complications that can reduce survival rates. Recently, the diagnostic criteria for acute kidney inj...
•
Season 7
•
Episode 1
•
38:30

EASL Studio Podcast: Arrivederci Milano, hallo Amsterdam!
Arrivederci Milano, hallo Amsterdam!FacultyAleksander Krag (Moderator)Debbie Shawcross (Moderator)Cyrielle Caussy (Faculty)Ana Lleo (Faculty)Francesco Negro (Faculty)Vlad Ra...
•
23:20

EASL Studio Podcast: Education at the heart of EASL’s mission
EASL Studio - Education at the heart of EASL’s missionFacultySven Francque (Moderator)Krista Rombouts (Faculty)Rajeshwar Mookerjee (Faculty)Henning Grønbæk (Faculty)All EASL Stud...
•
24:55
